Cargando…
A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis
BACKGROUND: Complications of diverticular disease are increasingly common, possibly linked to increasing obesity. Visceral fat could contribute to the development of symptomatic diverticular disease through its pro-inflammatory effects. OBJECTIVE: The study had 2 aims. A) to develop a semi-automated...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505945/ https://www.ncbi.nlm.nih.gov/pubmed/31067253 http://dx.doi.org/10.1371/journal.pone.0216528 |
_version_ | 1783416822387703808 |
---|---|
author | Murray, Kathryn A. Hoad, Caroline L. Garratt, Jill Kaviani, Mehri Marciani, Luca Smith, Jan K. Siegmund, Britta Gowland, Penny A. Humes, David J. Spiller, Robin C. |
author_facet | Murray, Kathryn A. Hoad, Caroline L. Garratt, Jill Kaviani, Mehri Marciani, Luca Smith, Jan K. Siegmund, Britta Gowland, Penny A. Humes, David J. Spiller, Robin C. |
author_sort | Murray, Kathryn A. |
collection | PubMed |
description | BACKGROUND: Complications of diverticular disease are increasingly common, possibly linked to increasing obesity. Visceral fat could contribute to the development of symptomatic diverticular disease through its pro-inflammatory effects. OBJECTIVE: The study had 2 aims. A) to develop a semi-automated algorithm to measure abdominal adipose tissue from 2-echo magnetic resonance imaging (MRI) data; B) to use this to determine if visceral fat was associated with bowel symptoms and inflammatory markers in patients with symptomatic and asymptomatic diverticular disease. DESIGN: An observational study measuring visceral fat using MRI together with serum adiponectin, leptin, stool calprotectin and patient-reported somatisation and bowel habit. SETTING: Medical and imaging research centres of a university hospital. PARTICIPANTS: MRI scans were performed on 55 patients after an overnight fast measuring abdominal subcutaneous and visceral adipose tissue volumes together with small bowel water content (SBWC). Blood and stool samples were collected and patients kept a 2 week stool diary and completed a somatisation questionnaire. MAIN OUTCOME MEASURES: Difference in the volume of visceral fat between symptomatic and asymptomatic patients. RESULTS: There were no significant differences in visceral (p = 0.98) or subcutaneous adipose (p = 0.60) tissue between symptomatic and asymptomatic patients. However measured fat volumes were associated with serum adipokines. Adiponectin showed an inverse correlation with visceral adipose tissue (VAT) (Spearman ρ = -0.5, p = 0.0003), which correlated negatively with SBWC (ρ = -0.3, p = 0.05). Leptin correlated positively with subcutaneous adipose tissue (ρ = 0.8, p < 0.0001). Overweight patients (BMI > 25 kgm(-2)) showed a moderate correlation between calprotectin and VAT (ρ = 0.3, p = 0.05). Somatization scores were significantly higher in symptomatic patients (p < 0.0003). CONCLUSIONS: Increasing visceral fat is associated with lower serum adiponectin and increased faecal calprotectin suggesting a pro-inflammatory effect which may predispose to the development of complications of diverticulosis. |
format | Online Article Text |
id | pubmed-6505945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-65059452019-05-23 A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis Murray, Kathryn A. Hoad, Caroline L. Garratt, Jill Kaviani, Mehri Marciani, Luca Smith, Jan K. Siegmund, Britta Gowland, Penny A. Humes, David J. Spiller, Robin C. PLoS One Research Article BACKGROUND: Complications of diverticular disease are increasingly common, possibly linked to increasing obesity. Visceral fat could contribute to the development of symptomatic diverticular disease through its pro-inflammatory effects. OBJECTIVE: The study had 2 aims. A) to develop a semi-automated algorithm to measure abdominal adipose tissue from 2-echo magnetic resonance imaging (MRI) data; B) to use this to determine if visceral fat was associated with bowel symptoms and inflammatory markers in patients with symptomatic and asymptomatic diverticular disease. DESIGN: An observational study measuring visceral fat using MRI together with serum adiponectin, leptin, stool calprotectin and patient-reported somatisation and bowel habit. SETTING: Medical and imaging research centres of a university hospital. PARTICIPANTS: MRI scans were performed on 55 patients after an overnight fast measuring abdominal subcutaneous and visceral adipose tissue volumes together with small bowel water content (SBWC). Blood and stool samples were collected and patients kept a 2 week stool diary and completed a somatisation questionnaire. MAIN OUTCOME MEASURES: Difference in the volume of visceral fat between symptomatic and asymptomatic patients. RESULTS: There were no significant differences in visceral (p = 0.98) or subcutaneous adipose (p = 0.60) tissue between symptomatic and asymptomatic patients. However measured fat volumes were associated with serum adipokines. Adiponectin showed an inverse correlation with visceral adipose tissue (VAT) (Spearman ρ = -0.5, p = 0.0003), which correlated negatively with SBWC (ρ = -0.3, p = 0.05). Leptin correlated positively with subcutaneous adipose tissue (ρ = 0.8, p < 0.0001). Overweight patients (BMI > 25 kgm(-2)) showed a moderate correlation between calprotectin and VAT (ρ = 0.3, p = 0.05). Somatization scores were significantly higher in symptomatic patients (p < 0.0003). CONCLUSIONS: Increasing visceral fat is associated with lower serum adiponectin and increased faecal calprotectin suggesting a pro-inflammatory effect which may predispose to the development of complications of diverticulosis. Public Library of Science 2019-05-08 /pmc/articles/PMC6505945/ /pubmed/31067253 http://dx.doi.org/10.1371/journal.pone.0216528 Text en © 2019 Murray et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Murray, Kathryn A. Hoad, Caroline L. Garratt, Jill Kaviani, Mehri Marciani, Luca Smith, Jan K. Siegmund, Britta Gowland, Penny A. Humes, David J. Spiller, Robin C. A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis |
title | A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis |
title_full | A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis |
title_fullStr | A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis |
title_full_unstemmed | A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis |
title_short | A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis |
title_sort | pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505945/ https://www.ncbi.nlm.nih.gov/pubmed/31067253 http://dx.doi.org/10.1371/journal.pone.0216528 |
work_keys_str_mv | AT murraykathryna apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT hoadcarolinel apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT garrattjill apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT kavianimehri apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT marcianiluca apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT smithjank apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT siegmundbritta apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT gowlandpennya apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT humesdavidj apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT spillerrobinc apilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT murraykathryna pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT hoadcarolinel pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT garrattjill pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT kavianimehri pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT marcianiluca pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT smithjank pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT siegmundbritta pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT gowlandpennya pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT humesdavidj pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis AT spillerrobinc pilotstudyofvisceralfatanditsassociationwithadipokinesstoolcalprotectinandsymptomsinpatientswithdiverticulosis |